David Hung, M.D.

David Hung, M.D.

DirectoratNuvation Bio· In proxies 2023–2025

Pay in FY2025+4% from the year before

David Hung, M.D. was paid $3.9M in FY2025 (Dec), up 4%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Nuvation Bio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NovoCurePublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. Nuvation BioPublic company · 3 yr
    • President and Chief Executive Officer2023 – Present · 3 yrNo stock prices for these years
  3. Director of Nuvation Bio Inc. since 2019. Formerly a director of ARYA Sciences Acquisition Corp. from 2018 to 2021, Inc. from 2017 to 2018Public company
    • Director? – PresentNo stock prices for these years
  4. Arya Sciences Acquisition Corp IIIPublic company
    • Director? – PresentNo stock prices for these years
  5. Establishment Labs HldgsPublic company
    • Director? – PresentNo stock prices for these years
  6. T TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  7. ARYA Sciences Acquisition Corp.Public company · 3 yr
    • Director2018 – 2021 · 3 yrNo stock prices for these years
  8. Establishment Labs Holdings Inc.Public company · 5 yr
    • Director2016 – 2021 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • NovoCureDirector · 7 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?